SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Candel Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of viral immunotherapies. Its pipeline includes CAN-2409 and CAN-3110. The company was founded by Estuardo Aguilar-Cordova in 2002 and is headquartered in Needham, MA.

Candel Therapeutics Inc

Candel Therapeutics is trending as investors focus on upcoming Phase 3 NSCLC trial milestones and anticipation of a BLA submission for its prostate cancer therapy, aglatimagene besadenovec. The community is actively discussing recent leadership additions, including a new Chief Commercial Officer, while speculating on the potential for strategic partnerships or future acquisition as the company transitions toward commercial readiness.

CRISPR Therapeutics AG is a gene editing company, which engages in the development of transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 platform. Its CRISPR/Cas9 platform is a gene editing technology that allows for precise, directed changes to genomic DNA. The firm offers a portfolio of therapeutic programs across a broad range of disease areas including hemoglobinopathies, oncology, regenerative medicine, and rare diseases. The company was founded by Rodger Novak, Emmanuelle Charpentier, Shaun Patrick Foy, Matthew Porteus, Daniel Anderson, Chad Cowan, and Craig Mellow on October 31, 2013 and is headquartered in Zug, Switzerland.

CRISPR Therapeutics AG

CRISPR Therapeutics is trending due to heightened speculation surrounding institutional positioning and potential buyout rumors, as traders monitor the company's progress in clinical trials and the commercial rollout of Casgevy. The community remains divided between long-term investors focused on the disruptive potential of gene editing and those frustrated by extended periods of price stagnation and management's capital-raising activities.

Barrick Mining Corp. engages in the production and sale of gold, copper, and related activities. It also provides exploration and mining development. It operates through the following business segments: Carlin, Cortez, Turquoise Ridge, Pueblo Viejo, Loulo-Gounkoto, Kibali, Veladero, North Mara, Bulyanhulu, and Other Mines. The company was founded by Peter D. Munk in 1983 and is headquartered in Toronto, Canada.

Barrick Mining Corp.

Barrick Mining Corp

Barrick Mining is trending as investors weigh the stock's role as a major gold and copper player amidst heightened geopolitical tension and supply chain instability in the Middle East. The community is actively discussing Barrick's robust free cash flow and share buyback potential, while monitoring how conflict-driven energy costs and the upcoming North American IPO could impact long-term valuation.

United Microelectronics Corp. is engaged in the semiconductor foundry company which provides IC fabrication services, focusing on logic and various technologies to serve all major sectors of the electronics industry. It offers complementary metal-oxide semiconductor logic wafers, mixed signal wafers, radio frequency complementary metal-oxide semiconductor wafers, embedded memory products, high voltage integrated circuits, and complementary metal-oxide semiconductor image sensors. The company was founded on May 22, 1980 and is headquartered in Hsinchu, Taiwan.

United Micro Electronics - ADR

United Microelectronics Corporation

United Microelectronics Corporation is gaining significant traction as investors pivot toward its specialized manufacturing capabilities and structural partnerships, particularly its 12nm FinFET collaboration with Intel. The community is actively discussing UMCs evolution from a mature node player into a critical AI infrastructure partner, with many long-term holders highlighting its fortress balance sheet and potential as an indispensable foundry alternative in the current semiconductor landscape.

Aave is a decentralized money market protocol where users can lend and borrow cryptocurrency across 20 different assets as collateral. The protocol has a native token called AAVE, which is also a governance token that lets the community decide the direction of the protocol in a collective manner. Lenders can&nbsp;earn interest by providing liquidity to the market, while borrowers can borrow by collateralizing their cryptoassets to take out loans from the liquidity pools.

AAVE

AAVE is drawing significant investor interest as the community weighs its long-term potential against direct competition with Compound and ongoing governance debates regarding token value accrual. Enthusiasts are highlighting its robust TVL and modular V4 protocol upgrades as key catalysts for sustained growth within the DeFi lending sector.

Harrow, Inc. engages in the development, production, and sale of innovative medications. It operates through the following segments: Pharmaceutical Compounding and Pharmaceutical Drug Development. The Pharmaceutical Compounding segment focuses on the operations of the ImprimisRx business. The company was founded by Mark L. Baum and Robert J. Kammer on January 11, 2006 and is headquartered in Nashville, TN.

Harrow Inc

Harrow Health Inc

Harrow Health is seeing significant community momentum driven by record weekly prescription growth for Vevye, alongside a massive expansion of the commercial sales team to capture market share. Investors are actively discussing the upcoming Q4 earnings report and the strategic long-term catalysts, including upcoming biosimilar launches and potential M&A activity, with many highlighting the stock's potential for significant price appreciation as the platform scales.

Personalis, Inc. engages in the provision of advanced genomic tests for cancer. The firm is also involved in providing sequencing and data analysis services to support population sequencing initiatives. The company was founded by Euan A. Ashley, Michael Snyder, Atul J. Butte, John S. West, and Russ B. Altman in February 2011 and is headquartered in Fremont, CA.

Personalis Inc

Personalis is generating significant investor buzz following a string of Medicare coverage approvals and a deepening commercial partnership with Tempus AI, which utilizes Personalis's NeXT Personal platform for its MRD testing. The community is actively discussing the company's long-term potential as a critical player in personalized cancer vaccines and oncological infrastructure, with many focusing on the transition from clinical volume growth to meaningful revenue realization as these coverage wins convert to commercial adoption.

First Solar, Inc. is a solar technology company, which engages in the provision of solar modules. It is involved in the design, manufacture, and sale of cadmium tellurid (CdTe) solar modules, which convert sunlight into electricity. The company was founded by Michael J. Ahearn in 1999 and is headquartered in Phoenix, AZ.

First Solar Inc

First Solar is experiencing heightened volatility as institutional investors navigate potential tariff shifts and sector-wide competition, with the community closely tracking recent utility-scale demand and the stock's structural role in AI data center expansion. While traders analyze complex options flow and technical support levels, many participants are evaluating whether the current valuation represents a deep-value opportunity or a long-term recovery cycle for the solar industry.

Rolls-Royce Holdings Plc designs, develops, manufactures, and services integrated power systems for use in the air, on land, and at sea. The company operates its business through following segments: Civil Aerospace, Power Systems, Defense and New Markets. The Civil Aerospace segment offers commercial aero engines and aftermarket services. The Power Systems segment includes engines, power systems and nuclear systems for civil power generation. The Defense segment consists of military aero engines, naval engines, submarines and aftermarket services. The New Markets segment includes development, manufacture and sales of small modular reactors (SMRs) and new electrical power solutions. The company was founded in March 1906 and is headquartered in London, the United Kingdom.

Rolls-Royce Holdings Plc - ADR

Rolls-Royce Holding PLC (ADR)

Rolls-Royce is trending as the community highlights significant contract momentum, particularly with Sweden's recent multi-billion pound selection of Rolls-Royce for small modular reactors (SMRs) and ongoing discussions regarding major defense and aviation projects. Investors remain highly focused on long-term bullish catalysts like the potential for widebody engine orders and the strategic importance of the company's expanding nuclear and defense pipeline in a volatile geopolitical environment.

Baidu, Inc. engages in the provision of internet search and online marketing solutions. The firm’s products and services include Baidu App, Baidu Search, Baidu Feed, Haokan, Quanmin, Baidu Post Bar, Baidu Knows, Baidu Encyclopedia, Baidu Input Method Editor or Baidu IME, Baidu AI Cloud and Overseas Products. It operates through the following segments: Baidu Core and iQIYI. The Baidu Core segment provides search-based, feed-based, and other online marketing services. The iQiyi segment is an online entertainment service provider, which offers original, professionally produced and partner-generated content on its platform. The company was founded by Yanhong Li and Xu Yong on January 18, 2000 and is headquartered in Beijing, China.

Baidu Inc - ADR

Baidu is trending as market participants weigh strong AI-driven growth metrics against regulatory scrutiny surrounding its autonomous vehicle operations and broader volatility in Chinese equities. Community discourse remains divided between long-term investors tracking chip and robotaxi catalysts and those wary of the stock's recent sensitivity to macroeconomic headwinds and geopolitical tensions.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Abpro Holdings, Inc. is a biotechnology company focused on the development of novel antibodies using discovery and engineering platforms for immuno-oncology, ophthalmology, and infectious disease. The company was founded in 2004 and is headquartered in Burlington, MA.

Abpro Holdings Inc.

Bullish Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Feed

News

Sentiment

Fundamentals

Info

ABPAbpro Holdings Inc.

Fundamentals

Latest ABP News